Tramadol Versus Celecoxib in Reducing Pain Associated With IUD Insertion
Status:
Unknown status
Trial end date:
2020-07-01
Target enrollment:
Participant gender:
Summary
Two hundred and ten women requesting IUD insertion will be randomly divided into three equal
groups. To ensure blinding the double dummy technique will be used in which group 1 will
receive Tramadol 100mg (Trama®, Global Napi, Giza, Egypt) orally in addition to a placebo
similar to Celecoxib, group 2 will receive Celecoxib 200mg (Celebrex® 200, Pfizer, USA) in
addition to a placebo similar to Tramadol, and group 3 will received a placebo similar to
Tramadol in addition to a placebo similar to Celecoxib. All the drugs will be given 2 hour
before the procedure.
After insertion of the IUD the women's pain perception will be assessed using a visual
analogue scale (VAS) graduated from zero to 10 with zero corresponding to no pain and 10
corresponding to the worst possible pain.